The evolution of the COVID-19 pandemic in paediatric patients with sickle cell disease: From Alpha to Omicron
Description
We compare the impact of SARS-CoV-2 variants on healthcare utilization and clinical presentation in paediatric patients with sickle cell disease (SCD). One hundred and ninety-one unique patients with SCD and positive SARS-CoV-2 polymerase chain
